Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion

Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age21-70
SponsorMilton S. Hershey Medical Center

About this trial

In this study, we are trying to see if vitamin B6 can minimize the amplified blood pressure response to exercise following ischemia-reperfusion injury. We are interested in a protein called P2X3, of which function can be blocked by vitamin B6, in the neurons of our nervous system. It is very important for blood pressure regulation. We would like to see if the P2X3 plays a role in patients' rising blood pressure during exercise. The results of the proposed studies will provide a base for those two potential economic and non-invasive inventions to improve the overall health and well-being of PAD patients.

Eligibility criteria

Qualifiers

Are males and females at least 21- 70 years of age (inclusive)

Capable of giving informed consent

Are of any race or ethnicity

Can communicate in English

Disqualifiers

< 21 years of age or > 70 years of age

Pregnant or nursing woman

Prisoners or institutionalized individuals unable to consent

Decisional impairment

Trial design

Treatments tested in this trial

  • Vitamin B6 25 MG
  • Vitamin B6 50 MG
  • Vitamin B6 100 MG
  • Placebo

Treatment groups

30 Participants
are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Milton S. Hershey Medical Center

Lead sponsor

American Heart Association

Collaborator